Huapont Life Sciences Co.,Ltd. (SHE:002004)
China · Delayed Price · Currency is CNY 4.630
-0.070 (-1.49%)
Nov 9, 2026, 3:04 PM CST
Huapont Life Sciences Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 2,847 | 2,858 | 3,290 | 3,783 | 4,187 | 4,386 |
Short-Term Investments | - | 1,925 | 1,556 | 1,197 | 799.5 | 605.52 |
Trading Asset Securities | 1,413 | 993.3 | 653.87 | 630.28 | 706.29 | 1,030 |
Cash & Short-Term Investments | 4,260 | 5,776 | 5,500 | 5,610 | 5,692 | 6,022 |
Cash Growth | 5.62% | 5.03% | -1.97% | -1.44% | -5.47% | 20.81% |
Accounts Receivable | 2,912 | 2,645 | 2,554 | 2,048 | 2,294 | 2,676 |
Other Receivables | 647.04 | 633.47 | 579 | 681.23 | 583.37 | 666.99 |
Receivables | 3,559 | 3,279 | 3,133 | 2,729 | 2,877 | 3,343 |
Inventory | 1,998 | 2,016 | 2,253 | 2,675 | 2,536 | 2,402 |
Prepaid Expenses | - | 248.88 | 260.4 | - | 3.88 | 14.94 |
Other Current Assets | 1,734 | 140.1 | 129.85 | 373.77 | 445.45 | 531.85 |
Total Current Assets | 11,551 | 11,460 | 11,277 | 11,387 | 11,554 | 12,314 |
Property, Plant & Equipment | 9,066 | 9,558 | 9,925 | 10,051 | 8,920 | 7,973 |
Long-Term Investments | 2,358 | 2,440 | 2,474 | 2,894 | 2,940 | 2,534 |
Goodwill | 1,976 | 1,976 | 2,032 | 2,740 | 2,948 | 3,440 |
Other Intangible Assets | 1,514 | 1,549 | 1,526 | 1,599 | 1,733 | 1,724 |
Long-Term Deferred Tax Assets | 512.71 | 480.17 | 525.93 | 434.04 | 342.15 | 266.23 |
Long-Term Deferred Charges | 411.1 | 469.27 | 575.07 | 540.53 | 558.56 | 570.14 |
Other Long-Term Assets | 1,316 | 1,097 | 1,116 | 1,082 | 1,033 | 1,218 |
Total Assets | 28,704 | 29,029 | 29,450 | 30,727 | 30,029 | 30,040 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,807 | 1,982 | 2,266 | 2,703 | 2,375 | 2,439 |
Accrued Expenses | 186.44 | 426.41 | 403.62 | 398.82 | 1,728 | 1,556 |
Short-Term Debt | 2,505 | 2,895 | 3,561 | 4,666 | 4,576 | 5,493 |
Current Portion of Long-Term Debt | 1,459 | 2,035 | 2,318 | 1,016 | 1,678 | 1,192 |
Current Portion of Leases | - | 13.04 | 13.98 | 12.62 | 9.52 | 9.44 |
Current Income Taxes Payable | 266.21 | 97.7 | 159.24 | 121.68 | 245.78 | 170.38 |
Current Unearned Revenue | 260.25 | 242.03 | 225.51 | 201.39 | 304.6 | 383.17 |
Other Current Liabilities | 1,710 | 1,422 | 1,468 | 1,515 | 193.96 | 146.13 |
Total Current Liabilities | 8,193 | 9,113 | 10,415 | 10,634 | 11,112 | 11,389 |
Long-Term Debt | 2,901 | 2,280 | 2,943 | 2,884 | 1,742 | 2,222 |
Long-Term Leases | 51.87 | 46.53 | 53.42 | 47.62 | 41.9 | 51.62 |
Long-Term Unearned Revenue | 293.8 | 306.8 | 266.87 | 271.23 | 278.21 | 258.13 |
Long-Term Deferred Tax Liabilities | 115.22 | 110.65 | 104.62 | 111.64 | 109.84 | 103.4 |
Other Long-Term Liabilities | 192.8 | 192.82 | 193.84 | 193.95 | 194.63 | 196.68 |
Total Liabilities | 11,748 | 12,050 | 13,977 | 14,143 | 13,478 | 14,221 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,980 | 1,980 | 1,980 | 1,980 | 1,980 | 1,980 |
Additional Paid-In Capital | 5,902 | 5,839 | 5,304 | 5,290 | 5,249 | 5,214 |
Retained Earnings | 2,232 | 2,451 | 2,183 | 2,920 | 3,050 | 3,089 |
Treasury Stock | -30 | -30 | -30 | - | - | - |
Comprehensive Income & Other | -40.94 | -20.35 | -100.67 | -84.95 | -87.55 | -176.15 |
Total Common Equity | 10,042 | 10,220 | 9,337 | 10,105 | 10,192 | 10,107 |
Minority Interest | 6,914 | 6,760 | 6,136 | 6,480 | 6,359 | 5,712 |
Shareholders' Equity | 16,956 | 16,979 | 15,473 | 16,585 | 16,551 | 15,819 |
Total Liabilities & Equity | 28,704 | 29,029 | 29,450 | 30,727 | 30,029 | 30,040 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 6,916 | 7,270 | 8,890 | 8,626 | 8,048 | 8,968 |
Net Cash (Debt) | -2,657 | -1,494 | -3,390 | -3,016 | -2,355 | -2,946 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.35 | -0.76 | -1.72 | -1.52 | -1.19 | -1.49 |
Filing Date Shares Outstanding | 1,973 | 1,973 | 1,973 | 1,976 | 1,980 | 1,980 |
Total Common Shares Outstanding | 1,973 | 1,973 | 1,973 | 1,980 | 1,980 | 1,980 |
Working Capital | 3,358 | 2,346 | 861.64 | 753.65 | 442.59 | 924.82 |
Book Value Per Share | 5.09 | 5.18 | 4.73 | 5.10 | 5.15 | 5.10 |
Tangible Book Value | 6,553 | 6,695 | 5,779 | 5,766 | 5,511 | 4,943 |
Tangible Book Value Per Share | 3.32 | 3.39 | 2.93 | 2.91 | 2.78 | 2.50 |
Buildings | - | 6,244 | 5,919 | 5,626 | 5,120 | 4,570 |
Machinery | - | 8,841 | 8,462 | 7,632 | 6,765 | 6,051 |
Construction In Progress | - | 894.88 | 1,154 | 1,869 | 1,434 | 1,464 |